Vimarsana
Biggest News Aggregation in the World

Egbert Smit News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Egbert Smit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Egbert Smit Today - Breaking & Trending Today

Dutch-based MLA Diagnostics raises funds for clinical trials in tailored skin cancer treatments - Vimarsana News

Dutch-based MLA Diagnostics raises funds for clinical trials in tailored skin cancer treatments

Published: December 4, 2023

Netherlands-based MLA Diagnostics, a company focused on enhancing personalised treatments for skin cancer patients, has secured fresh funding to advance its

Source: siliconcanals.com
Related Topics:
Manon Van EngelandEgbert SmitMaastricht University Medical CenterHealth VenturesLimburg Startup Capital FundHealth Impact FundBrightlands Maastricht Health CampusLimburg Business Development FundBrightlands Life Sciences VenturesMaastricht UniversityImpact FundBrightlands Life Science VenturesBusiness Development FundLife Sciences VenturesMaastricht University Medical
Merck: European Commission Approves TEPMETKO (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations - Vimarsana News

Merck: European Commission Approves TEPMETKO (tepotinib) for Patients with Advanced NSCLC with METex14 Skipping Alterations

Published: February 18, 2022

TEPMETKO is the first and only oral MET inhibitor to be approved in the European Economic Area for treating adult patients with advanced NSCLC harboring alterations leading to METex14 skipping,

Source: finanznachrichten.de
Related Topics:
United StatesEgbert SmitAnne Marie BairdAndrew PatersonEuropean CommissionDrug AdministrationNetherlands Cancer InstituteEuropean Economic AreaProfessor Egbert SmitNetherlands CancerNew England JournalLung CancerChief Marketing OfficerProduct CharacteristicsEnglj MedAccessed February